Skip to content
APOD75

Drawing based on the label description. No photo yet.

“75 mg capsules consisting of hypromellose capsule shells with a buff opaque body, light blue opaque cap, imprinted "APO" on cap and "D75" on body in black ink”

APO D75 pill

Pill with imprint APO D75 is yellow, capsule, 18 mm and has been identified as Dabigatran Etexilate 75 mg. It is used for blood clots in the veins and blood clots in the lungs. It is supplied by Apotex Corp.

Dabigatran Etexilate 75 mg

Imprint
APO D75
Strength
75 mg
Used for
Blood clots in the veins and blood clots in the lungs
Color
Yellow
Shape
Capsule / oblong
Size
18 mm
Score
No score line
Form
Capsule
Manufacturer
Apotex Corp
NDC
60505-4347, 60505-4347-6, 60505-4347-2

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dabigatran Etexilate pills and guides

What is Dabigatran Etexilate used for?

Dabigatran Etexilate is used for blood clots in the veins and blood clots in the lungs.

Official uses from the US prescribing label

Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation in Adult Patients

Dabigatran Etexilate Capsules is indicated to reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation.

Treatment of Deep Venous Thrombosis and Pulmonary Embolism in Adult Patients

Dabigatran Etexilate Capsules is indicated for the treatment of deep venous thrombosis and pulmonary embolism in adult patients who have been treated with a parenteral anticoagulant for 5 to 10 days.

Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism in Adult Patients

Dabigatran Etexilate Capsules is indicated to reduce the risk of recurrence of deep venous thrombosis and pulmonary embolism in adult patients who have been previously treated.

Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism in Adult Patients Following Hip Replacement Surgery

Dabigatran Etexilate Capsules is indicated for the prophylaxis of deep vein thrombosis and pulmonary embolism in adult patients who have undergone hip replacement surgery.

Treatment of Venous Thromboembolic Events in Pediatric Patients

Dabigatran Etexilate Capsules is indicated for the treatment of venous thromboembolic events (VET) in pediatric patients 8 to less than 18 years of age who have been treated with a parenteral anticoagulant for at least 5 days.

Reduction in the Risk of Recurrence of Venous Thromboembolic Events in Pediatric Patients

Dabigatran Etexilate Capsules is indicated to reduce the risk of recurrence of VTE in pediatric patients 8 to less than 18 years of age who have been previously treated.

From the FDA-approved label on DailyMed (published Aug 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows APO D75. The parts can be split between the two sides, so turn the pill over and check both.
  • It is yellow, capsule, 18 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Dabigatran Etexilate Mesylate

Inactive: Fumaric Acid, Magnesium Stearate, Mannitol, Ferric Oxide Red, Ferric Oxide Yellow, Fd&c Blue No. 1, Titanium Dioxide, Shellac, Potassium Hydroxide, Hypromellose, Unspecified, Ferrosoferric Oxide, Silicon Dioxide, Croscarmellose Sodium, Ammonia, Propylene Glycol

Other pills with imprint APO D75

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dabigatran Etexilate pills